Loading...All listed services and products are For Research Use Only. Do Not use in any diagnostic or therapeutic applications.
GPR88, encoded by the GPR88 gene located at human chromosome 1p21.2, is a member of the G protein-coupled receptor family. It is a seven-transmembrane receptor of the rhodopsin-like class that couples to the G(i) subfamily of G proteins. The protein comprises 384 amino acids with a molecular weight of approximately 40 kDa, and it is predominantly expressed in the striatum of the brain. Rather than having a well-defined endogenous ligand, GPR88 is classified as an orphan receptor whose activation regulates intracellular signaling through G(i)-mediated pathways. It modulates motor activity, spatial learning, and emotional processing, and it has been reported to attenuate dopamine D1 receptor-mediated responses.
GPR88 is a striatum-enriched G protein-coupled receptor that participates in the regulation of neuronal signaling and behavior. Through G(i)-coupled signaling, it influences intracellular cAMP responses and modulates the activity of dopaminergic signaling pathways in striatal neurons. Its restricted expression and role in motor and cognitive function make GPR88 a useful target for research on striatal circuit function, G protein-coupled receptor signaling, and the molecular basis of motor regulation.
Fig. 1 GPR88 Regulates Neuronal Cilia.1
GPR88, encoded by the GPR88 gene, functions as a striatum-specific orphan G protein-coupled receptor that regulates neuronal signaling and behavior:
Creative Biolabs offers high-quality GPR88 membrane proteins produced using optimized expression systems, including full-length receptor and isolated extracellular domain variants. As a seven-transmembrane G protein-coupled receptor, GPR88 is suitable for studies of receptor signaling, G protein coupling, and striatal function. These membrane protein products can support investigation of G(i)-mediated signaling and the regulation of striatal circuits. All GPR88 membrane proteins undergo strict quality control to support consistent performance across applicable research platforms.
Not finding the protein product you need? Contact us to start your one-stop custom service!
Creative Biolabs provides custom-engineered GPR88 stable cell lines, including overexpression and blank control models. These cell lines are optimized for studies of G protein-coupled receptor signaling and striatal function. Each cell line undergoes stringent validation to ensure stable expression profiles and consistent functional performance in diverse experimental contexts.
Not finding the stable cell line product you need? Contact us to start your one-stop custom service!
High-specificity recombinant antibodies targeting GPR88 are developed using antibody engineering technologies for research applications involving GPR88 expression and localization. These antibodies can be used in studies of GPR88 distribution in the striatum and may also support characterization of GPR88 signaling in combination with appropriate G protein detection reagents.
Not finding the recombinant antibody product you need? Contact us to start your one-stop custom service!
Beyond catalog products, Creative Biolabs offers specialized custom services for GPR88 research:
GPR88 is a striatum-specific orphan G protein-coupled receptor that couples to G(i) proteins and regulates intracellular cAMP signaling, influencing motor and cognitive function.
GPR88 is a striatum-enriched receptor that modulates dopaminergic signaling and motor function, and studying it informs the molecular mechanisms of striatal circuit regulation and G protein-coupled receptor signaling.
No, all GPR88 products and services are strictly for research use only, not intended for clinical diagnosis or treatment.
Offerings include full-length GPR88 membrane proteins, custom GPR88 stable cell lines, and GPR88-specific recombinant antibodies for striatal signaling research.
GPR88 products are suitable for studies of G protein-coupled receptor signaling, G(i) coupling, cAMP regulation, and striatal function.